International Assets Investment Management LLC Sells 176 Shares of iShares Biotechnology ETF $IBB

International Assets Investment Management LLC trimmed its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 5.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,959 shares of the financial services provider’s stock after selling 176 shares during the period. International Assets Investment Management LLC’s holdings in iShares Biotechnology ETF were worth $374,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Moors & Cabot Inc. increased its holdings in iShares Biotechnology ETF by 2.0% in the 1st quarter. Moors & Cabot Inc. now owns 29,053 shares of the financial services provider’s stock valued at $3,716,000 after buying an additional 558 shares during the period. IFP Advisors Inc increased its stake in iShares Biotechnology ETF by 23.9% in the first quarter. IFP Advisors Inc now owns 19,849 shares of the financial services provider’s stock valued at $2,539,000 after acquiring an additional 3,831 shares during the period. N.E.W. Advisory Services LLC bought a new stake in iShares Biotechnology ETF in the first quarter valued at about $45,000. John G Ullman & Associates Inc. bought a new stake in iShares Biotechnology ETF in the first quarter valued at about $230,000. Finally, SBI Securities Co. Ltd. grew its stake in shares of iShares Biotechnology ETF by 5.2% in the 1st quarter. SBI Securities Co. Ltd. now owns 2,198 shares of the financial services provider’s stock valued at $281,000 after purchasing an additional 108 shares during the period. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Trading Down 1.4%

IBB stock opened at $153.92 on Thursday. iShares Biotechnology ETF has a 1-year low of $107.43 and a 1-year high of $157.19. The business’s 50 day moving average is $144.20 and its 200-day moving average is $132.09.

iShares Biotechnology ETF Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, September 19th. Stockholders of record on Tuesday, September 16th were issued a $0.0828 dividend. The ex-dividend date of this dividend was Tuesday, September 16th. This represents a $0.33 annualized dividend and a dividend yield of 0.2%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.